WeLeader Biomedical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,062	991.13	940.7	1,036	841.14
Revenue Growth (YoY)	9.05%	5.36%	-9.17%	23.13%	-
Cost of Revenue	717.13	674.8	642.62	743.97	622.22
Gross Profit	344.9	316.32	298.08	291.75	218.92
Selling, General & Admin	107.75	102.13	100.59	97.64	86.26
Operating Expenses	107.52	102.19	100.12	97.11	86.65
Operating Income	237.38	214.14	197.96	194.64	132.28
Interest Expense	-6.1	-5.8	-5.69	-4.21	-6.16
Interest & Investment Income	2.43	1.29	0.59	0.24	0.08
Other Non Operating Income (Expenses)	4.74	5.2	2.27	1.88	4.85
EBT Excluding Unusual Items	238.44	214.83	195.13	192.54	131.04
Gain (Loss) on Sale of Investments	0.23	0.4	0.1	-0.68	0.01
Gain (Loss) on Sale of Assets	-	-0.02	-1.69	0.69	0.41
Pretax Income	238.68	215.21	193.55	192.55	131.46
Income Tax Expense	47.66	44.99	41.26	38.75	25.69
Net Income	191.02	170.21	152.28	153.8	105.77
Net Income to Common	191.02	170.21	152.28	153.8	105.77
Net Income Growth	14.34%	11.77%	-0.98%	45.40%	-
Shares Outstanding (Basic)	44	42	41	30	28
Shares Outstanding (Diluted)	44	42	41	30	28
Shares Change (YoY)	5.47%	1.55%	35.00%	8.28%	-
EPS (Basic)	4.34	4.09	3.74	5.13	3.79
EPS (Diluted)	4.33	4.08	3.71	5.05	3.76
EPS Growth	8.21%	9.97%	-26.53%	34.31%	-
Free Cash Flow	46.1	108.06	117.13	-379.09	216.43
Free Cash Flow Per Share	1.04	2.59	2.85	-12.46	7.70
Dividend Per Share	3.368	3.368	2.300	0.860	0.450
Dividend Growth	46.43%	46.43%	167.44%	91.11%	-
Gross Margin	32.48%	31.92%	31.69%	28.17%	26.03%
Operating Margin	22.35%	21.61%	21.04%	18.79%	15.73%
Profit Margin	17.99%	17.17%	16.19%	14.85%	12.57%
Free Cash Flow Margin	4.34%	10.90%	12.45%	-36.60%	25.73%
EBITDA	265.95	242.96	227.58	226.65	165.64
EBITDA Margin	25.04%	24.51%	24.19%	21.88%	19.69%
D&A For EBITDA	28.57	28.83	29.62	32.01	33.36
EBIT	237.38	214.14	197.96	194.64	132.28
EBIT Margin	22.35%	21.61%	21.04%	18.79%	15.73%
Effective Tax Rate	19.97%	20.91%	21.32%	20.13%	19.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.